It was reported that another subtype of ginsenoside, Rg3, could inhibit lactate production in ovarian cancer cells [23], and similarly, we observed that Rh2 could significantly reduce the level of lactate produced by NSCLC cells and decrease their uptake of glucose. Here, RHAG is linked to ovarian carcinoma.